There’s a dearth of data about how differences in gender, ethnicity, and environment can affect the aging process.

Words of hope, in Arabic calligraphy, were incised into the building’s facade and matched precisely in its interior walls. By David Belcher The ruler of Dubai was found to have hacked the phones of ...

The hotel is located on 7th Avenue, in the heart of Ybor City's nightlife district. Suites have large balconies that run the length of the rooms and have enough seating for multiple people. Everyone ...

Many drugs available and in development work by targeting proteins, an approach that comes with limitations. For one, proteins are not the root cause of disease, said Samir Ounzain, co-founder and CEO ...

The most obviously qualified candidate in the field though likely not favorite. A two-time Olympic champion runner in the 1,500 meters; led the winning bid and organizing of the 2012 London Olympics; ...

Anne Hathaway is making a royal return to Genovia as Princess Mia Thermopolis in "The Princess Diaries 3." The Academy Award-winning actress confirmed that she would reprise her famous role in the ...

The Princess of Wales and her only daughter were together in much of the unprecedented home video Janine Henni is a Royals Staff Writer for PEOPLE Digital, covering modern monarchies and the world's ...

London — Catherine, the Princess of Wales, says she's finished her course of chemotherapy and is looking forward to returning to work as she enters a "new phase of recovery" from cancer. Princess Kate ...

Princess Kate is sharing a major update in her cancer journey. The Princess of Wales, 42, revealed in a video on Monday that she feels "relief" after completing her chemotherapy treatment. She said ...

Eli Lilly’s hunt for obesity targets has led it to the dark genome. The Big Pharma has put together a deal worth up to $1 billion in biobucks to partner with Haya Therapeutics to find multiple ...

LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)--HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics for chronic diseases, today ...

Samir Ounzain, PhD, co-founder and CEO of HAYA Therapeutics The noncoding portion that makes up 98% of the human genome is anything but “junk” to HAYA Therapeutics, which said it is partnering with ...